SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

58 hedge funds and large institutions have $147M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$684K
Puts
$9K
Net Calls
Net Calls Change

Top Buyers

1 +$11.5M
2 +$10.5M
3 +$8.46M
4
AG
Artal Group
Luxembourg
+$8.02M
5
SB
Samsara BioCapital
California
+$7.05M

Top Sellers

1 -$397K
2 -$203K
3 -$114K
4
SC
Shay Capital
New York
-$93.9K
5
LPL Financial
LPL Financial
California
-$67.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.4M
2
$19.5M
3
$16.1M
4
$13.9M
5
$13M
6
$11.5M
7
$10.1M
8
$8.46M
9
$6.45M
10
$5.96M
11
$2.8M
12
$1.96M
13
$1.92M
14
$1.87M
15
$1.67M
16
$1.26M
17
$1.01M
18
$806K
19
$662K
20
$654K
21
$635K
22
$623K
23
$457K
24
$428K
25
$426K